Structure-based maximal affinity model predicts small-molecule druggability

Molecular Properties That Influence the Oral Bioavailability of Drug Candidates

Daniel F. Veber, Stephen R. Johnson, Hung‐Yuan Cheng et al. · Journal of Medicinal Chemistry · 2002 · 8.1K citations

Pharmacy, Pharmacokinetics, Pharmacology +15

In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

Lyubomir T. Vassilev, Binh Thanh Vu, Bradford Graves et al. · Science · 2004 · 4.7K citations

Medicine, Oncology, Pharmacology +15

Structural Mechanism for Statin Inhibition of HMG-CoA Reductase

Eva S. Istvan, J. Deisenhofer · Science · 2001 · 1.6K citations

Life Sciences, Biochemistry, Molecular Biology +15

Influenza Neuraminidase Inhibitors Possessing a Novel Hydrophobic Interaction in the Enzyme Active Site:  Design, Synthesis, and Structural Analysis of Carbocyclic Sialic Acid Analogues with Potent Anti-Influenza Activity

Choung U. Kim, Willard Lew, Matthew A. Williams et al. · Journal of the American Chemical Society · 1997 · 1.1K citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Anatomy of protein pockets and cavities: Measurement of binding site geometry and implications for ligand design

Jie Liang, Clare Woodward, Herbert Edelsbrunner · Protein Science · 1998 · 1.1K citations · Full text

Life Sciences, Biochemistry, Bioinformatics +17